Jeeva Clinical Trials Inc

Revenue-stage AI SaaS Delivering Smarter Designs and Faster Execution of Clinical Trials Without Chaos With Our Unified AI-ready Clinical Operating System

  • Stage Product In Market
  • Industry Software
  • Location Manassas, VA, USA
  • Currency USD
  • Founded February 2019
  • Employees 10
  • Incorporation Type C-corp
  • Website jeevatrials.com

Company Summary

Jeeva is attacking $95B Clinical trials management market to help biopharma and CROs streamline the FDA drug development process with our unified B2B SaaS powered by Agentic AI. Real-time AI-assisted collaboration enables smarter protocols, reduced risks, & min burden. 24+ trusted clients and 45,000+ users/patients since inception; Jeeva has ~$502K ARR YTD and expects $1M+ ARR within the next 6 months. Delivering Clinical Trials Without Chaos.

Team

Advisors

Previous Investors

  • Frank Sasinowski, MS, MPH, JD
    Unconfirmed
    Alex Euler
    Ike Syed
  • Infinity Opportunity Fund
    Unconfirmed
    Chaya Dwarkanath
    Unconfirmed
    Shivakumar Vijayan
  • Mohan Bangalore, Ph.D. GSK Executive
    Unconfirmed
    Srini Kankanahalli, Ph.D. Technology Entrepreneur and Investor
    Unconfirmed
    Sathish Hasige, Ph.D. Senior Executive at AstraZeneca
    Unconfirmed
  • Sam Sarkar - Technology Entrepreneur and Angel Investor
    Unconfirmed
    Nagesh Bashyam - Health Tech Entrepreneur and Angel Investor
    Unconfirmed
    Sharat Kayapanda
    Unconfirmed
  • Mahesh Naithani
    Unconfirmed
    Venkat Koka
    Unconfirmed
    Kiran Mysore
  • Scott Schliebner
    Hiranjith Govindamangalam
    MatchPlayGroup
    Unconfirmed
  • BLPN Emerging Fund
    Unconfirmed
    Ray Jordan - BLPN
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free